Last reviewed · How we verify
BUCCOTHERM® Sensitive Gums with Fluoride
BUCCOTHERM® Sensitive Gums with Fluoride is a marketed product developed by I.M. Sechenov First Moscow State Medical University, currently holding a niche position in the oral care market. The key strength of this product lies in its unique formulation, which is protected by a key composition patent expiring in 2028. The primary risk is the lack of significant revenue data and key trial results, which may limit its competitive edge against established players in the market.
At a glance
| Generic name | BUCCOTHERM® Sensitive Gums with Fluoride |
|---|---|
| Sponsor | I.M. Sechenov First Moscow State Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: